271 related articles for article (PubMed ID: 20854129)
1. Fetoprotective activity of breast cancer resistance protein (BCRP, ABCG2): expression and function throughout pregnancy.
Hahnova-Cygalova L; Ceckova M; Staud F
Drug Metab Rev; 2011 Feb; 43(1):53-68. PubMed ID: 20854129
[TBL] [Abstract][Full Text] [Related]
2. Effect of oxygen on multidrug resistance in the first trimester human placenta.
Lye P; Bloise E; Dunk C; Javam M; Gibb W; Lye SJ; Matthews SG
Placenta; 2013 Sep; 34(9):817-23. PubMed ID: 23790363
[TBL] [Abstract][Full Text] [Related]
3. Interactions of tenofovir and tenofovir disoproxil fumarate with drug efflux transporters ABCB1, ABCG2, and ABCC2; role in transport across the placenta.
Neumanova Z; Cerveny L; Ceckova M; Staud F
AIDS; 2014 Jan; 28(1):9-17. PubMed ID: 24413260
[TBL] [Abstract][Full Text] [Related]
4. Role of breast cancer resistance protein (Bcrp/Abcg2) in fetal protection during gestation in rat.
Cygalova L; Ceckova M; Pavek P; Staud F
Toxicol Lett; 2008 May; 178(3):176-80. PubMed ID: 18450391
[TBL] [Abstract][Full Text] [Related]
5. Expression and functional activity of breast cancer resistance protein (BCRP, ABCG2) transporter in the human choriocarcinoma cell line BeWo.
Ceckova M; Libra A; Pavek P; Nachtigal P; Brabec M; Fuchs R; Staud F
Clin Exp Pharmacol Physiol; 2006; 33(1-2):58-65. PubMed ID: 16445700
[TBL] [Abstract][Full Text] [Related]
6. Placental P-glycoprotein and breast cancer resistance protein: influence of polymorphisms on fetal drug exposure and physiology.
Hutson JR; Koren G; Matthews SG
Placenta; 2010 May; 31(5):351-7. PubMed ID: 20347140
[TBL] [Abstract][Full Text] [Related]
7. BCRP/ABCG2 in the placenta: expression, function and regulation.
Mao Q
Pharm Res; 2008 Jun; 25(6):1244-55. PubMed ID: 18202831
[TBL] [Abstract][Full Text] [Related]
8. Maternal bacterial infections impact expression of drug transporters in human placenta.
Petrovic V; Kojovic D; Cressman A; Piquette-Miller M
Int Immunopharmacol; 2015 Jun; 26(2):349-56. PubMed ID: 25912346
[TBL] [Abstract][Full Text] [Related]
9. Expression and transport activity of breast cancer resistance protein (Bcrp/Abcg2) in dually perfused rat placenta and HRP-1 cell line.
Staud F; Vackova Z; Pospechova K; Pavek P; Ceckova M; Libra A; Cygalova L; Nachtigal P; Fendrich Z
J Pharmacol Exp Ther; 2006 Oct; 319(1):53-62. PubMed ID: 16809480
[TBL] [Abstract][Full Text] [Related]
10. ABCB1 and ABCG2 expression in the placenta and fetus: an interspecies comparison.
Myllynen P; Kummu M; Sieppi E
Expert Opin Drug Metab Toxicol; 2010 Nov; 6(11):1385-98. PubMed ID: 20738225
[TBL] [Abstract][Full Text] [Related]
11. Effect of oxygen on multidrug resistance in term human placenta.
Javam M; Audette MC; Iqbal M; Bloise E; Gibb W; Matthews SG
Placenta; 2014 May; 35(5):324-30. PubMed ID: 24685282
[TBL] [Abstract][Full Text] [Related]
12. Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense.
Leslie EM; Deeley RG; Cole SP
Toxicol Appl Pharmacol; 2005 May; 204(3):216-37. PubMed ID: 15845415
[TBL] [Abstract][Full Text] [Related]
13. Kinetic analysis of the cooperation of P-glycoprotein (P-gp/Abcb1) and breast cancer resistance protein (Bcrp/Abcg2) in limiting the brain and testis penetration of erlotinib, flavopiridol, and mitoxantrone.
Kodaira H; Kusuhara H; Ushiki J; Fuse E; Sugiyama Y
J Pharmacol Exp Ther; 2010 Jun; 333(3):788-96. PubMed ID: 20304939
[TBL] [Abstract][Full Text] [Related]
14. Placental passage of olomoucine II, but not purvalanol A, is affected by p-glycoprotein (ABCB1), breast cancer resistance protein (ABCG2) and multidrug resistance-associated proteins (ABCCs).
Hofman J; Kučera R; Neumanova Z; Klimes J; Ceckova M; Staud F
Xenobiotica; 2016; 46(5):416-23. PubMed ID: 26364927
[TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor-mediated activation of the map kinase cascade results in altered expression and function of ABCG2 (BCRP).
Meyer zu Schwabedissen HE; Grube M; Dreisbach A; Jedlitschky G; Meissner K; Linnemann K; Fusch C; Ritter CA; Völker U; Kroemer HK
Drug Metab Dispos; 2006 Apr; 34(4):524-33. PubMed ID: 16415123
[TBL] [Abstract][Full Text] [Related]
16. Glucocorticoid regulation of placental breast cancer resistance protein (Bcrp1) in the mouse.
Petropoulos S; Gibb W; Matthews SG
Reprod Sci; 2011 Jul; 18(7):631-9. PubMed ID: 21602547
[TBL] [Abstract][Full Text] [Related]
17. Expression of breast cancer resistance protein (BCRP/ABCG2) in human placenta throughout gestation and at term before and after labor.
Yeboah D; Sun M; Kingdom J; Baczyk D; Lye SJ; Matthews SG; Gibb W
Can J Physiol Pharmacol; 2006 Dec; 84(12):1251-8. PubMed ID: 17487233
[TBL] [Abstract][Full Text] [Related]
18. An update on expression and function of P-gp/ABCB1 and BCRP/ABCG2 in the placenta and fetus.
Han LW; Gao C; Mao Q
Expert Opin Drug Metab Toxicol; 2018 Aug; 14(8):817-829. PubMed ID: 30010462
[TBL] [Abstract][Full Text] [Related]
19. Impact of breast cancer resistance protein on cancer treatment outcomes.
Ross DD; Nakanishi T
Methods Mol Biol; 2010; 596():251-90. PubMed ID: 19949928
[TBL] [Abstract][Full Text] [Related]
20. ABCG2 -- a transporter for all seasons.
Sarkadi B; Ozvegy-Laczka C; Német K; Váradi A
FEBS Lett; 2004 Jun; 567(1):116-20. PubMed ID: 15165903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]